Freland Groupsp. z o.o.

Other professional, scientific and technical activities, not elsewhere classified

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2017-11-21
Share capital
5,000.00 PLN
Registered address
ul. Stefana Batorego 48, 41-500 Chorzów, Poland
Electronic delivery address
AE:PL-21066-28802-HWUFD-31

Financials

Revenue history (in k)

Filing timeliness

Financial statements were filed on time, on average 97 days early.

  • 202501/04/2026
  • 202420/03/2025
  • 202321/03/2024
  • 202229/05/2023
  • 202127/04/2022
  • 202020/06/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue
This companyUSD 49.44kMedianUSD 52.52kAverageUSD 569.42k
Net profit
This companyUSD -4.51kMedianUSD 3.63kAverageUSD 38.84k
Operating costs
This companyUSD 52.97kMedianUSD 44.77kAverageUSD 505.17k
Assets
This companyUSD 37.43kMedianUSD 37.43kAverageUSD 835.39k

Authorized Representatives

Elżbieta Pyka Frydman – President of the Management Board
Remigiusz Pyka – Attorney-in-fact (sole)

Manner of representation

Each member of the management board is authorized to make declarations on behalf of the company independently.

Ownership

OwnerSharesShare valueStake
Jan Frydmanage 79
10$135.0610%
Elżbieta Zofia Pyka Frydmanage 74
90$1,215.5690%

Elżbieta Zofia Pyka Frydman and Jan Frydman hold a combined 100% – the ownership structure indicates family control.

Beneficial owners

Person

Debt

No entries in the National Debtors Register (KRZ).

Public aid

4 public aid cases recorded, with a total value of $2,142.

PurposeGross amount
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$368
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$270
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$222

FAQ

Last updated: 2026-10-07